Artelo biosciences, inc. (ARTL)
Balance Sheet / Yearly
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Aug'14
Assets [Abstract]
Current Assets
Cash and cash equivalents - end of period

1,982

3,374

4,423

286

457

115

337

326

525

412

572

227

10

3

3

3

3

3

17

12

8

14

Prepaid expenses

-

-

-

-

17

46

35

57

13

16

1

-

-

-

-

-

-

-

-

-

-

-

Other receivable

-

-

-

-

-

-

-

16

1

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid Expense, Current

97

86

8

26

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

291

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits Assets, Current

1

1

1

540

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Receivables, Gross, Current

29

45

8

6

8

3

22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets, Current

2,111

3,507

4,442

1,152

483

164

396

400

540

429

574

227

13

3

3

3

3

3

17

12

8

14

Property, Plant and Equipment, Net

1

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Intangible Assets, Net (Excluding Goodwill)

2,039

2,039

2,039

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets

4,152

5,547

6,482

1,153

484

165

396

400

541

430

574

227

13

3

3

3

3

3

17

12

8

14

LIABILITIES AND STOCKHOLDER'S EQUITY
Liabilities, Current [Abstract]
Accounts Payable and Other Accrued Liabilities, Current

431

574

348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

912

586

634

529

489

324

133

28

71

2

10

12

8

7

2

1

-

1

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

1

0

-

-

-

-

-

-

-

-

-

Due to Related Parties, Current

12

10

3

6

5

5

2

2

1

2

0

7

0

0

4

4

0

0

-

-

-

-

Fair value ? August 31, 2019

-

-

29

100

584

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts Payable, Current

-

-

639

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable, net of discount of $431

-

-

-

-

-

-

-

-

-

-

-

29

29

-

-

-

-

-

-

-

-

-

Stock payable

-

-

-

-

-

-

-

-

-

-

-

231

-

-

-

-

-

-

-

-

-

-

Liabilities, Current

444

584

1,021

1,018

1,176

640

531

492

325

136

29

341

32

10

17

13

8

3

1

-

1

0

Total Liabilities

-

-

-

-

-

-

-

-

-

-

-

341

32

10

-

13

8

3

1

0

1

0

Stockholder's Equity
Preferred Stock, Value, Issued

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

-

0

-

-

Common stock, $0.001 par value; 75,000,000 shares authorized; 6,850,000 issued and outstanding

3

3

3

2

15

14

1

12

12

11

11

9

7

7

7

7

7

7

7

6

6

6

Additional Paid in Capital, Total

11,175

11,070

10,278

4,107

2,923

2,713

2,514

1,856

1,575

855

827

55

-

-

38

-

-

-

-

-

-

-

Subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

55

55

-

38

38

38

38

31

24

24

Accumulated deficit

-7,487

-6,117

-4,810

-3,965

-3,620

-3,195

-2,638

-1,948

-1,370

-572

-295

-179

-82

-69

-60

-55

-50

-45

-30

-25

-

-15

Accumulated Other Comprehensive Income (Loss), Net of Tax

15

6

-9

-10

-10

-7

-12

-11

-1

-0

0

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

-

Balances

3,708

4,963

5,461

134

-692

-475

-134

-91

215

294

544

-113

-19

-6

-13

-9

-4

0

15

12

6

14

Liabilities and Equity

4,152

5,547

6,482

1,153

484

165

396

400

541

430

574

227

13

3

3

3

3

3

17

12

8

14